Willow Acquires Elvie to Enhance Women’s Health Innovation

Deal News | Apr 03, 2025 | Orrick

In a significant move within the FemTech sector, Willow, known for pioneering wearable breast pumps, has acquired Elvie, a leading UK innovator in women's health. The strategic acquisition is expected to bolster Willow's product offerings by integrating Elvie's expertise in smart pelvic tools and breast pumps. The collaboration aims to create a multifaceted global platform providing a wide array of maternal health solutions. Sarah OLeary, CEO of Willow, conveyed the company's commitment to leveraging this acquisition to advance innovations in maternal health on a global scale.

Sectors

FemTech
Medical Device Technology

Geography

United States – Willow, the acquiring company, is based in the United States, making this geography relevant to the transaction.
United Kingdom – Elvie, the acquired company, is a UK-based innovator in women's health, highlighting the relevance of this geography.

Industry

FemTech – The article involves companies focused on female technology, particularly innovations related to women's health and maternal care.
Medical Device Technology – Both Willow and Elvie are involved in creating medical devices, such as breast pumps and smart pelvic tools, which are central to this acquisition.

Financials

Not Disclosed – The financial terms of the acquisition between Willow and Elvie have not been disclosed.

Participants

Name	Role	Type	Description
Willow	Acquiring Company	Company	Willow is a FemTech leader known for inventing the first fully in-bra wearable breast pump.
Elvie	Target Company	Company	Elvie is a leading UK FemTech innovator specializing in women's health products, including breast pumps and pelvic tools.
Orrick	Legal Advisor	Company	Orrick is the legal advisor for Willow in its acquisition of Elvie.
Sarah OLeary	CEO of Willow	Person	Sarah OLeary is the CEO of Willow, guiding the company through its acquisition and strategic expansion.